A temporal switch in the insulin-signalling pathway that regulates hepatic IGF-binding protein-1 gene expression

Journal of Molecular Endocrinology

Volumn 37, Issue 2, 2006, Pages 227-237

  Finlay, David ^a   Ruiz Alcaraz, Antonio J ^a   Lipina, Christopher ^a   Perrier, Stephanie ^a   Sutherland, Calum D ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN BINDING PROTEIN 1;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; ENZYME ACTIVATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GLUCOSE HOMEOSTASIS; HORMONE ACTION; IMMUNOPRECIPITATION; INSULIN RESISTANCE; LIVER CELL CARCINOMA; LONG TERM EXPOSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA ISOLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CYCLOHEXIMIDE; DOWN-REGULATION; GENE EXPRESSION REGULATION; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; LIVER; MODELS, BIOLOGICAL; PROTEIN KINASES; RATS; SIGNAL TRANSDUCTION; SIROLIMUS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 33750319702     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.1.02084     Document Type: Article

References (55)

1. Alessi DR & Downes CP 1998 The role of PI 3-kinase in insulin action. Biochimica et Biophysica Acta 1436 151-164.
2. Band CJ & Posner BI 1997 PI 3-kinase and p70S6 kinase are required for insulin but not bisperoxovanadium 1,10-phenanthroline inhibition of IGFBP gene expression. Journal of Biological Chemistry 272 138-145.
3. Becard D, Hainault I, Azzout-Marniche D, Bertry-Coussot L, Ferre P & Foufelle F 2001 Adenovirus-mediated overexpression of sterol regulatory element binding protein-1c mimics insulin effects on hepatic gene expression and glucose homeostasis in diabetic mice. Diabetes 50 2425-2430.
4. Beck T & Hall MN 1999 The TOR signalling pathway controls nuclear localisation of nutrient-regulated transcription factors. Nature 402 689-692.
5. Beugnet A, Tee AR, Taylor PM & Proud CG 2003 Regulation of Largets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability. Biochemical Journal 372 555-566.
6. Cantley LC 2002 The PI 3-kinase pathway. Science 296 1655-1657.
7. Chan T-F, Carvalho J, Riles L & Zheng XFS 2000 A chemical genomics approach toward understanding the global functions of the target of rapamycin protein (TOR). PNAS 97 13227-13232.
8. Cichy SB, Uddin S, Danilkovitch A, Guo S, Klippel A & Unterman TG 1998 PKB mediates effects of insulin on hepatic IGFBP1 gene expression through a conserved insulin response sequence. Journal of Biological Chemistry 273 6482-6487.
9. Denton RM & Tavare JM 1995 Does mitogen-activated-protein kinase have a role in insulin action? The cases for and against European Journal of Biochemistry 227 597-611.
10. Dickens M, Svitek CA, Culbert AA, O'Brien RM & Tavare JM 1998 Central role for PI 3-kinase in the repression of glucose-6-phosphatase gene transcription by insulin. Journal of Biological Chemistry 273 20144-20149.
11. Dufner A & Thomas G 1999 Ribosomal S6 kinase signaling and control of translation. Experimental Cell Research 253 100-109.
12. Durham SK, Suwanichkul A, Scheimann AO, Yee D, Jackson JG, Barr FG & Powell DR 1999 FKHR binds the insulin response element in the insulin-like growth factor binding protein-1 promoter. Endocrinology 140 3140-3146.
13. Finlay D, Patel S, Dickson LM, Shpiro N, Marquez R, Rhodes CJ & Sutherland C 2004 Glycogen synthase kinase-3 regulates IGFBP-1 gene transcription through the thymine-rich insulin response element: inhibition is required for full regulation of this promoter element by insulin. BMC Molecular Biolology 5 15.
14. Fisher TL & White MF 2004 Signaling pathways: the benefits of good communication. Current Biology 14 RI005-R1007.
15. Forest CD, O'Brien RM, Lucas PC, Magnuson MA & Granner DK 1990 Regulation of PEPCK gene expression by insulin. Use of the stable transfection approach to locate an insulin responsive sequence. Molecular Endocrinology 4 1302-1310.
16. Gan L, Han Y, Bastianetto S, Dumont Y, Unterman TG & Quirion R 2005a FoxO-dependent and -independent mechanisms mediate SirT1 effects on IGFBP-1 gene expression. Biochemical and Biophysical Research Communications 337 1092-1096.
17. Gan L, Pan H & Unterman TG 2005b Insulin response sequence-dependent and -independent mechanisms mediate effects of insulin on glucocorticoid-stimulated insulin-like growth factor binding protein-1 promoter activity. Endocrinology 146 4274-4280.
18. Gingras A-C, Raugbt B & Sonenberg N 2001 Regulation of translation initiation by FRAP/mTOR. Genes and Development 15 807-826.
19. Granner DK & Pilkis S 1990 The genes of hepatic glucose metabolism. Journal of Biological Chemistry 265 10173-10178.
20. Granner DK & O'Brien RM 1992 Molecular physiology and genetics of NIDDM. Diabetes Care 15 369-395.
21. Goo S, Rena G, Cichy S, He X, Cohen P & Unterman TG 1999 Phosphorylation of Ser 256 by PKB disrupts transactivation by FKHR and mediates effects of insulin on IGFBP-1 promoter activity through a conserved insulin response sequence. Journal of Biological Chemistry 274 17184-17192.
22. Hall RK & Granner DG 1999 Insulin regulates expression of metabolic genes through divergent signaling pathways. Journal of Basic and Clinical Physiology and Pharmacology 10 119-133.
23. Hanson RW & Reshef L 1997 Regulation of PEPCK gene expression. Annual Review of Biochemistry 66 581-611.
24. Hara K, Yonezawa K, Weng QP, Kozlowski MT, Belham C & Avruch J 1998 Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. Journal of Biological Chemistry 273 14484-14494.
25. Kahn CR 1994 Insulin action, diabetogenes and the cause of type II diabetes. Diabetes 43 1066-1084.
26. Koo SH, Flechner L, Qi L, Zhang X, Screaton RA, Jeffries S, Hedrick S, Xu W, Boussouar F, Brindle P et al. 2005 The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437 1109-1111.
27. Kozma S, Lane HA, Ferrari S, Luther H, Siegmann M & Thomas G 1989 A stimulated S6 kinase from rat liver: identity with the mitogen activated S6 kinase of 3T3 cells. EMBO Journal 8 412-4132.
28. Lochhead PA, Coghlan MP, Rice SQJ & Sutherland C 2001 Inhibition of GSK3 selectively reduces G6Pase and PEPCK gene expression. Diabetes 50 937-947.
29. Nordlie RC & Foster JD 1999 Regulation of glucose production by the liver. Annual Review of Nutrition 19 379-406.
30. O'Brien RM & Granner DK 1990 PEPCK gene as a model of inhibitory effects of insulin on gene transcription. Diabetes Care 13 327-339.
31. O'Brien RM & Granner DK 1996 Regulation of gene expression by insulin. Physiological Reviews 76 1109-1161.
32. Ooi GK, Brown DR, Suh D-S, Tseng LY-H & Rechler MM 1993 Cycloheximide stabilises IGFBP-1 mRNA and inhibits IGFBP-1 transcription in H411E cells. Journal of Biological Chemistry 268 16664-16672.
33. Orlowski CC, Ooi GT, Brown DR, Yang YW, Tseng LY & Rechler MM 1991 Insulin rapidly inhibits insulin-like growth factor-binding protem-1 gene expression in H4-II-E rat hepatoma cells. Molecular Endocrinology 5 1180-1187.
34. Patel S, Lochhead PA, Rena G & Sutherland C 2001 Antagonistic effects of phorbol esters on insulin regulation of IGFBP-1 but not glucose-6-phosphatase gene expression. Biochemical Journal 359 611-619.
35. Patel S, Lochhead PA, Rena G, Fumagalli S, Pende M, Kozma S, Thomas GM & Sutherland C 2002 Insulin regulation of IGF-binding protem-1 gene expression is dependent on mammalian target of rapamycin (mTOR), but independent of S6K activity. Journal of Biological Chemistry 277 9889-9895.
36. Patel S, Lipina C & Sutherland C 2003 Different mechanisms are used by insulin to repress three genes that contain a homologous thymine-rich insulin response element. FEBS Letters 549 72-76.
37. Pilkis SJ & Granner DK 1992 Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Annual Review of Physiology 54 885-909.
38. Price DJ, Nemenoff RA & Avruch J 1989 Purification of a hepatic S6 kinase from cycloheximide-treated rats. Journal of Biological Chemistry 264 13825-13833.
39. Puigserver P, Rhee J, Donovan J, Walkey CJ, Yoon JC, Oriente F, Kitamura Y, Altomonte J, Dong H, Accili D et al. 2003 Insulin-regulated hepatic gluconeogenesis through FOXO1-PGG-1alpha interaction. Nature 423 550-555.
40. Raught B, Gingras A-C & Sonenberg N 2001 The target of rapamycin (TOR) proteins. PNAS 98 7037-7044.
41. Rena G, Guo S, Cichy SC, Unterman TG & Cohen P 1999 Phosphorylation of the transcription factor forkhead family member FKHR by PKB. Journal of Biological Chemistry 274 17179-17183.
42. Schmelzle T & Hall MN 2000 TOR, a central controller of cell growth. Cell 103 253-262.
43. Schmoll D, Walker KS, Alessi DR, Grempler R, Burchell A, Guo S, Walther R & Unterman TG 2000 Regulation of glucose-6-phosphatase gene expression by protein kinase B(alpha) and the forkhead transcription factor FKHR. Journal of Biological Chemistry 275 36324-36333.
44. Shamji AF, Kuruvilla FG & Schreiber SL 2000 Partitioning the transcriptional program induced by rapamycin among the effectors of the Tor proteins. Current Biology 10 1574-1581.
45. Shigemitsu K, Tsujishita Y, Hara K, Nanahoshi M, Avruch J & Yonezawa K 1999 Regulation of translational effectors by amino acid and mammalian target of rapamycin signaling pathways. Journal of Biological Chemistry 274 1058-1065.
46. Shulman GI 2000 Cellular mechanisms of insulin resistance. Journal of Clinical Investigation 106 171-176.
47. Siegal MR & Sisler HD 1963 Inhibition of protein synthesis in vitro by cycloheximide. Nature 200 675-676.
48. Sutherland C & Cohen P 1994 The α-isoform of glycogen synthase kinase-3 from rabbit skeletal muscle is inactivated by p70 S6 kinase or MAP kinase-activated protein kinase-1 in vitro. FEBS Letters 338 37-42.
49. Sutherland C, Leighton IA & Cohen P 1993 Inactivation of glycogen synthase kinase-3β by phosphorylation; new kinase connections in insulin and growth factor signalling. Biochemical Journal 296 15-19.
50. Sutherland C, O'Brien RM & Granner DK 1995 Phosphatidylinositol 3-kinase, but not p70/p85 ribosomal S6 protein kinase, is required for the regulation of Phosphoenolpyruvate Carboxykinase gene expression by insulin. Journal of Biological Chemistry 270 15501-15506.
51. Sutherland C, O'Brien RM & Granner DK 2003 Genetic regulation of glucose metabolism. In Handbook of Physiology, pp 707-734. Eds LS Jefferson & AD Cherrington. New York: Oxford University Press.
52. Thomas G & Hall MN 1997 TOR signalling and control of cell growth. Current Opinion in Cell Biology 9 782-787.
53. Unterman TG, Oehler DT, Murphy LJ & Lacson RG 1991 Multi-hormonal regulation of insulin-like growth factor-binding protein-1 in rat H4IIE hepatoma cells: the dominant role of insulin. Endocrinology 128 2693-2701.
54. Vlahos CJ, Matter WF, Hui KY & Brown RF 1994 A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). Journal of Biological Chemistry 269 5241-5248.
55. Zhou XY, Shibusawa N, Naik K, Porras D, Temple K, Ou H, Kaihara K, Roe MW, Brady MJ & Wondisford FE 2004 Insulin regulation of hepatic gluconeogenesis through phosphorylation of CREB-binding protein. Nature Medicine 10 633-637.